Following in the footsteps of smallpox: Can we achieve the global eradication of measles?

BMC International Health and Human Rights

Volumn 4, Issue , 2004, Pages 1-5

  Morgan, Oliver W C ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; DISEASE COURSE; DRUG EFFICACY; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HUMAN; INFECTION CONTROL; INTERNATIONAL COOPERATION; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MORTALITY; NUTRITIONAL STATUS; SEROTYPE; SMALLPOX; UNITED NATIONS; VIRUS CARRIER; VIRUS IDENTIFICATION; VIRUS IMMUNITY; WORLD HEALTH ORGANIZATION;

EID: 2942668058     PISSN: 1472698X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-698X-4-1     Document Type: Article

References (31)

1. 25th Anniversary of the last case of naturally acquired smallpox. Morb Mortal Wkly Rep 2002, 51:952.
2. Duke T, Mgone CS: Measles: not just another viral exanthem. Lancet 2003, 361:763-773.
3. Update: Global measles control and mortality reduction -worldwide, 1991 - 2001. Morb Mortal Wkly Rep 2003, 52:471-475.
4. Henao-Restrepo AM, Strebel P, Hoestra EJ, Birmingham M, Bilous J: Experience in global measles control. The Journal of Infectious Diseases 2003, 187(Suppl 1):S15-21.
5. de Quadros CA: History and prospects for viral disease eradication. Med Microbiol Immunol 2002, 191:75-81.
6. Foege WH: Confronting emerging infections: lessons from the smallpox eradication campaign. Emerg Infect Dis 1998, 4:412-413.
7. Radetsky M: Smallpox: a history of its rise and fall. Pediatr Infect Dis J 1999, 18:85-93.
8. Chin J: Control of Communicable Disease Manual. 17th edition. Washington D.C., American Public Health Association; 2000.
9. Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S: The unfinished measles immunisation agenda. The Journal of Infectious Diseases 2003, 187(Suppl 1):S1-7.
10. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organisation, and CDC. MMWR Recomm Rep 1997, 46:1-20.
11. Salisbury D, Begg N: Immunisation Against Infectious Disease. London, HMSO; 1996.
12. Kuroiwa C, Xayyavong P, Vongphrachanh P, Khampapongpane B, Yamanka M, Nakumura S: Difficulties in measles elimination: prevalence of measles antibodies before and after mass vaccination campaign in Laos. Vaccine 2003, 21:479-484.
13. Adu FD, Akinwolere OA, Tomori O, Uche LN: Low seroconversion rates to measles vaccine among children in Nigerian. Bull World Health Organ 1992, 70:457-460.
14. Bautista-Lopez N, Vaisberg A, Kanashiro R, Hernandez H, Ward BJ: Immune response to measles vaccine in Peruvian children. Bull World Health Organ 2001, 79:1038-1046.
15. Dai B, Chen ZH, Liu QC, Wu T, Guo CY, Xingzi WZ, Fang HH, Xiang YZ: Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 1991, 69:415-423.
16. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin A: Immune response to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001, 184:817-826.
17. Andre FE: Vaccinology: past achievements, present roadblocks and future promises. Vaccine 2003, 21:593-595.
18. Aaby P, Samb B, Simondon F, Coll Seck AM, Knudsen K, Whittle H: Non-specific beneficial effects of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995, 311:481-485.
19. Kabir Z, Long J, Reddaiah VP, Kevany J, Kapoor SK: Non-specific effects of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study. Bull World Health Organ 2003, 81:244-250.
20. Shann F: A little bit of measles does you good. British Medical Journal 1999, 319:4-5.
21. Initiative for Vaccine Research: State of the art of new vaccines research and development. Geneva, World Health Organisation; 2003.
22. de Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G: Progress towards measles eradication in the region of the Americas. J Infect Dis 2003, 187(Suppl 1):S102-10.
23. World Health Organisation, United Nations Children's Fund: Measles. Mortality Reduction and Regional Elimination Strategic Plan 2001 - 2005. Geneva; 2001.
24. Featherstone D, Brown D, Sanders R: Development of the Global Measles Laboratory Network. J Infect Dis 2003, 187(Suppl 1):S264-9.
25. Bellini WJ, Helfand RF: The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 2003, 187(Suppl 1):S283-90.
26. Cliff J, Simango A, Augusto O, Vand der Paal L, Biellik R: Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozam-bique (1998-2001). J Infect Dis 2003, 187(Suppl 1):S51-7.
27. Obaro SK, Palmer A:Vaccines for children: policies, politics and poverty. Vaccine 2003, 21:1423-1431.
28. World Health Organisation [http://www.who.int/mediacentre/releases/2003/pr76/en/]
29. Measles Initiative [[http://www.measlesinitiative.org]]
30. GAVI: the Vaccine Alliance [[http://www.vaccinealliance.org]]
31. Global measles mortality reduction and regional elimination 2000-2001. Can Commun Dis Rep 2002, 28:81-88.